DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20220416

Prevalence of pulmonary arterial hypertension in severe chronic obstructive pulmonary disease patients attending tertiary care centre Ernakulam

Jilse George, Niranjan A. V., Tara B. Nair, Minhaj .

Abstract


Background: Chronic obstructive pulmonary disease (COPD) is an irreversible bronchial inflammation of lung airways and parenchyma. Various factors play an important role in occurrence and severity of pulmonary arterial hypertension (PAH), a common in severe COPD. The objective of the study is to know the proportion of PAH in patients with severe COPD and to find the association between various factors.

Methods: 180 cases of severe COPD patients admitted in Government Medical College Ernakulum from January 2019-December 2019, were enrolled into this cross-sectional descriptive study. Subject’s history, clinical examination, anthropometric measurements, vitals, Arterial Blood Gas (ABG) analysis were done.

Results: Among 180 subjects, 148 (82.22%) had mild PAH, 22 (12.22%) subjects had moderate PAH and 10 (5.56%) had severe PAH. Use of accessory muscle was the most elicited sign in the study with 174 (96.67%). 170 (94.44%) had cough and 169 (93.89%) had breathlessness which were the most reported symptoms. Demographic variables and clinical features had no significant mean pulmonary artery pressure (mPAP) association. Grade 3 PAH groups were elder than others, which was statistically significant (p<0.047). FEV1, Oxygen Saturation and ejection fraction were lowest in grade 3 PAH subjects. Respiratory rate, hemoglobin, PCV, tricuspid velocity, PaCO2 were highest in grade 3 PAH subjects being statistically significant (p<0.0001).

Conclusions: In our study, majority of severe COPD patients had mild PAH.  There was an independent correlation between respiratory rate, hemoglobin, PCV, tricuspid regurgitant velocity and PaCO2 with severity of PAH.


Keywords


COPD, mPAP, PAH, Tricuspid valve regurgitant velocity

Full Text:

PDF

References


Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. European respiratory journal. 2009;33(5):1165-85.

Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. European Respiratory Journal. 2008;32(5):1371-85.

Farber HW, Loscalzo J. Pulmonary arterial hypertension. New England Journal of Medicine. 2004;351(16):1655-65.

Lee-Chiong Jr TL, Matthay RA. Pulmonary hypertension and cor pulmonale in COPD. InSeminars in respiratory and critical care medicine. 2003;4(3):263-72.

Montani D, Günther S, Dorfmüller P, Perros F, Girerd B, Garcia G et al. Pulmonary arterial hypertension. Orphanet journal of rare diseases. 2013;8(1):1-28.

Murphy ML, Adamson J, Hutcheson F. Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med. 1974;81:307-13.

Fluck DC, Chandrasekar RG, Gardner FV. Left ventricular hypertrophy in chronic bronchitis. Br Heart J. 1966;28:92-7.

Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K et al. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ primary care respiratory medicine. 2021;31(1):1-1.

Mete B, Pehlivan E, Gülbaş G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int J Chron Obstruct Pulmon. Dis. 2018;13:3307-12.

Cederholm T. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49-64.

Fekri MS, Torabi M, Shoul SA, Mirzaee M. Prevalence and predictors associated with severe pulmonary hypertension in COPD. The American journal of emergency medicine. 2018;36(2):277-80.

Mahishale V, Patil B, Rathi A, Sindhuri A, Eti A. Screening of Chronic Obstructive Pulmonary Disease patients for pulmonary arterial hypertension using two-dimensional transthoracic doppler echocardiography in tertiary care hospital in India. Heart India. 2015;3(3):66.

Fekri MS, Bajgani SM, Rasti A, Yazdani R, Mollaie HR. Detection of helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction. Jundishapur journal of microbiology. 2015;8(1).

Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India: official organ of Indian Chest Society. 2011;28(2):105.